EMA Finds No Pancreas Risks with Incretins

(MedPage Today) -- The European Medicines Agency has cleared incretin drugs for type 2 diabetes of an association with pancreatic risks.

Source: MedPage Today Cardiovascular - July 29, 2013 Category: Cardiology Source Type: news